Patients with Deleterious Germline Variants in STXBP2 Develop Toxicity after CAR-T Cell Therapy with Axicabtagene Ciloleucel
In: Blood, Jg. 140 (2022-11-15), S. 646-647
Online
unknown
Zugriff:
Titel: |
Patients with Deleterious Germline Variants in STXBP2 Develop Toxicity after CAR-T Cell Therapy with Axicabtagene Ciloleucel
|
---|---|
Autor/in / Beteiligte Person: | Leick, Mark B. ; Han, Seunghun ; Kathleen M.E. Gallagher ; Silva, Harrison ; Martin, Grace ; Camp, Sabrina ; Chu, Hoyin ; Gillani, Riaz ; Kann, Michael C. ; Choi, Bryan D. ; Larson, Rebecca ; Phillips, Merle ; Kienka, Tamina ; Bailey, Stefanie R. ; Graham, Charlotte ; Reilly, Christopher R. ; Jan, Max ; Gonzalez, Elba ; Horick, Nora K. ; Budka, Justin ; Filosto, Simone ; Shen, Rhine R. ; Eliezer Van Allen ; Saud H AlDubayan ; Maus, Marcela V. |
Link: | |
Zeitschrift: | Blood, Jg. 140 (2022-11-15), S. 646-647 |
Veröffentlichung: | American Society of Hematology, 2022 |
Medientyp: | unknown |
ISSN: | 1528-0020 (print) ; 0006-4971 (print) |
DOI: | 10.1182/blood-2022-166322 |
Schlagwort: |
|
Sonstiges: |
|